search
PRIMA BCI
Trends
- 1Science Corp Reports 36-Month PRIMA Trial Restores Vision in Blind Patients●Science Corp. Announces Long-Term (36 Months) Results of PRIMA BCI Clinical Trial Showing Durable Vision Restoration in Blind Patients Suffering from Geographic Atrophy
Science Corp. has announced long-term results from its PRIMA brain-computer interface clinical trial, reporting durable vision restoration over 36 months in blind patients suffering from geographic atrophy, an advanced form of age-related macular degeneration. The company says the findings demonstrate the implant's lasting benefit, a milestone for neurotechnology and vision restoration research.